Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 May;92(2):239–244. doi: 10.1111/j.1365-2249.1993.tb03386.x

Increased IL-6 gene expression and production in patients with common variable immunodeficiency.

F Pandolfi 1, R Paganelli 1, A Oliva 1, I Quinti 1, V Polidori 1, E Fanales-Belasio 1, E Guerra 1, F Aiuti 1
PMCID: PMC1554818  PMID: 8485909

Abstract

We have studied IL-6 gene expression and production by in vitro stimulated peripheral blood mononuclear cells (PBMC) isolated from common variable immunodeficiency (CVI) patients. A strong hybridization signal for the IL-6 probe was observed in mRNA extracted from phytohaemagglutinin (PHA)- and PHA/phorbol myristate acetate (PMA)-stimulated PBMC from most of 12 CVI patients analysed. IL-6 production by PHA-stimulated PBMC from 28 CVI patients was evaluated in ELISA and found to be significantly (P < 0.0001) higher than in normal controls. IL-6 production, however, did not correlate with the lymphocyte populations examined, nor with the absolute number of monocytes. We have also showed that IL-6 was able to increase IgM secretion by several Epstein-Barr virus (EBV)-transformed cell lines derived from both normal donors and CVI patients, but it failed to modify substantially the amounts of IgM and IgG produced in vitro by PBMC derived from CVI patients and activated with pokeweed mitogen (PWM) or anti-IgM. Our data indicate that IL-6 gene expression and production is increased in CVI, but CVI cells do not respond to IL-6 with increased production of immunoglobulin.

Full text

PDF
239

Images in this article

241Fig. 1
on p.241

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelman D. C., Matsuda T., Hirano T., Kishimoto T., Saxon A. Elevated serum interleukin-6 associated with a failure in B cell differentiation in common variable immunodeficiency. J Allergy Clin Immunol. 1990 Oct;86(4 Pt 1):512–521. doi: 10.1016/s0091-6749(05)80207-6. [DOI] [PubMed] [Google Scholar]
  2. Ambrus J. L., Jr, Haneiwich S., Chesky L., McFarland P., Peters M. G., Engler R. J. Abnormal response to a human B cell growth factor in patients with common variable immunodeficiency (CVI). J Allergy Clin Immunol. 1991 Jun;87(6):1138–1149. doi: 10.1016/0091-6749(91)92160-3. [DOI] [PubMed] [Google Scholar]
  3. Bertolini J. N., Benson E. M. The role of human interleukin-6 in B-cell isotype regulation and differentiation. Cell Immunol. 1990 Jan;125(1):197–209. doi: 10.1016/0008-8749(90)90074-2. [DOI] [PubMed] [Google Scholar]
  4. Brenner M. K., North M. E., Chadda H. R., Newton C. A., Malkovsky M., Webster A. D., Farrant J. The role of B cell differentiation factors and specific T cell help in the pathogenesis of primary hypogammaglobulinemia. Eur J Immunol. 1984 Nov;14(11):1021–1027. doi: 10.1002/eji.1830141111. [DOI] [PubMed] [Google Scholar]
  5. Cunningham-Rundles C. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol. 1989 Jan;9(1):22–33. doi: 10.1007/BF00917124. [DOI] [PubMed] [Google Scholar]
  6. Cunningham-Rundles S., Cunningham-Rundles C., Siegal F. P., Gupta S., Smithwick E. M., Kosloff C., Good R. A. Defective cellular immune response in vitro in common variable immunodeficiency. J Clin Immunol. 1981 Jan;1(1):65–72. doi: 10.1007/BF00915478. [DOI] [PubMed] [Google Scholar]
  7. Eibl M. M., Mannhalter J. W., Zielinski C. C., Ahmad R. Defective macrophage--T-cell interaction in common varied immunodeficiency. Clin Immunol Immunopathol. 1982 Mar;22(3):316–322. doi: 10.1016/0090-1229(82)90048-4. [DOI] [PubMed] [Google Scholar]
  8. Fiedler W., Sykora K. W., Welte K., Kolitz J. E., Cunningham-Rundles C., Holloway K., Miller G. A., Souza L., Mertelsmann R. T-cell activation defect in common variable immunodeficiency: restoration by phorbol myristate acetate (PMA) or allogeneic macrophages. Clin Immunol Immunopathol. 1987 Aug;44(2):206–218. doi: 10.1016/0090-1229(87)90066-3. [DOI] [PubMed] [Google Scholar]
  9. Harriman G. R., Kunimoto D. Y., Elliott J. F., Paetkau V., Strober W. The role of IL-5 in IgA B cell differentiation. J Immunol. 1988 May 1;140(9):3033–3039. [PubMed] [Google Scholar]
  10. Horii Y., Muraguchi A., Suematsu S., Matsuda T., Yoshizaki K., Hirano T., Kishimoto T. Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/IL-6 by T cells. J Immunol. 1988 Sep 1;141(5):1529–1535. [PubMed] [Google Scholar]
  11. Ishizaka A., Sakiyama Y., Nakanishi M., Tomizawa K., Oshika E., Kojima K., Taguchi Y., Kandil E., Matsumoto S. The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes. Clin Exp Immunol. 1990 Mar;79(3):392–396. doi: 10.1111/j.1365-2249.1990.tb08101.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kishimoto T. The biology of interleukin-6. Blood. 1989 Jul;74(1):1–10. [PubMed] [Google Scholar]
  13. Kruger G., Welte K., Ciobanu N., Cunningham-Rundles C., Ralph P., Venuta S., Feldman S., Koziner B., Wang C. Y., Moore M. A. Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency. J Clin Immunol. 1984 Jul;4(4):295–303. doi: 10.1007/BF00915297. [DOI] [PubMed] [Google Scholar]
  14. Malkovský M., Jíra M., Gao L., Loveland B., Malkovska V., Dalgleish A. G., Webster A. D. Reduced expression of interleukin-2 receptors in hypogammaglobulinaemia: a possible cause of higher cancer incidence. Lancet. 1986 Jun 21;1(8495):1442–1443. doi: 10.1016/s0140-6736(86)91586-2. [DOI] [PubMed] [Google Scholar]
  15. Matheson D. S., Green B. J. Defect in production of B cell differentiation factor-like activity by mononuclear cells from a boy with hypogammaglobulinemia. J Immunol. 1987 Apr 15;138(8):2469–2472. [PubMed] [Google Scholar]
  16. Mayer L., Fu S. M., Cunningham-Rundles C., Kunkel H. G. Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors. J Clin Invest. 1984 Dec;74(6):2115–2120. doi: 10.1172/JCI111636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Muraguchi A., Hirano T., Tang B., Matsuda T., Horii Y., Nakajima K., Kishimoto T. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med. 1988 Feb 1;167(2):332–344. doi: 10.1084/jem.167.2.332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. North M. E., Webster A. D., Farrant J. Role of interleukin-2 and interleukin-6 in the mitogen responsiveness of T cells from patients with 'common-variable' hypogammaglobulinaemia. Clin Exp Immunol. 1990 Sep;81(3):412–416. doi: 10.1111/j.1365-2249.1990.tb05348.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pandolfi F., Corte G., Quinti I., Fiorilli M., Frieligsdorf A., Bargellesi A., Aiuti F. Defect of T helper lymphocytes, as identified by the 5/9 monoclonal antibody, in patients with common variable hypogammaglobulinaemia. Clin Exp Immunol. 1983 Mar;51(3):470–474. [PMC free article] [PubMed] [Google Scholar]
  20. Pandolfi F., Quinti I., Frielingsdorf A., Goldstein G., Businco L., Aiuti F. Abnormalities of regulatory T-cell subpopulations in patients with primary immunoglobulin deficiencies. Clin Immunol Immunopathol. 1982 Mar;22(3):323–330. doi: 10.1016/0090-1229(82)90049-6. [DOI] [PubMed] [Google Scholar]
  21. Pandolfi F., Trentin L., San Martin J. E., Wong J. T., Kurnick J. T., Moscicki R. A. T cell heterogeneity in patients with common variable immunodeficiency as assessed by abnormalities of T cell subpopulations and T cell receptor gene analysis. Clin Exp Immunol. 1992 Aug;89(2):198–203. doi: 10.1111/j.1365-2249.1992.tb06932.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pastorelli G., Roncarolo M. G., Touraine J. L., Peronne G., Tovo P. A., de Vries J. E. Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens. Clin Exp Immunol. 1989 Dec;78(3):334–340. [PMC free article] [PubMed] [Google Scholar]
  23. Paul W. E., Ohara J. B-cell stimulatory factor-1/interleukin 4. Annu Rev Immunol. 1987;5:429–459. doi: 10.1146/annurev.iy.05.040187.002241. [DOI] [PubMed] [Google Scholar]
  24. Pereira S., Webster D., Platts-Mills T. Immature B cells in fetal development and immunodeficiency: studies of IgM, IgG, IgA and IgD production in vitro using Epstein-Barr virus activation. Eur J Immunol. 1982 Jul;12(7):540–546. doi: 10.1002/eji.1830120703. [DOI] [PubMed] [Google Scholar]
  25. Perri R. T., Weisdorf D. J. Impaired responsiveness to B cell growth factor in a patient with common variable hypogammaglobulinemia. Blood. 1985 Aug;66(2):345–349. [PubMed] [Google Scholar]
  26. Reinherz E. L., Cooper M. D., Schlossman S. F., Rosen F. S. Abnormalities of T cell maturation and regulation in human beings with immunodeficiency disorders. J Clin Invest. 1981 Sep;68(3):699–705. doi: 10.1172/JCI110305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rodriguez M. A., Bankhurst A. D., Williams R. C., Jr Characterization of the suppressor activity in lymphocytes from patients with common variable hypogammaglobulinemia: evidence for an associated primary B-cell defect. Clin Immunol Immunopathol. 1983 Oct;29(1):35–50. doi: 10.1016/0090-1229(83)90005-3. [DOI] [PubMed] [Google Scholar]
  28. Rubinstein A., Sicklick M., Mehra V., Rosen F. S., Levey R. H. Antihelper T cell autoantibody in acquired agammaglobulinemia. J Clin Invest. 1981 Jan;67(1):42–50. doi: 10.1172/JCI110031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Saiki O., Ralph P., Cunningham-Rundles C., Good R. A. Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci U S A. 1982 Oct;79(19):6008–6012. doi: 10.1073/pnas.79.19.6008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Saiki O., Shimizu M., Saeki Y., Kishimoto S., Kishimoto T. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient. J Immunol. 1984 Oct;133(4):1920–1924. [PubMed] [Google Scholar]
  31. Siegal F. P., Siegal M., Good R. A. Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients. J Clin Invest. 1976 Jul;58(1):109–122. doi: 10.1172/JCI108439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Smith C. I., Möller G., Severinson E., Hammarström L. Frequencies of interleukin-5 mRNA-producing cells in healthy individuals and in immunoglobulin-deficient patients, measured by in situ hybridization. Clin Exp Immunol. 1990 Sep;81(3):417–422. doi: 10.1111/j.1365-2249.1990.tb05349.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sneller M. C., Strober W. Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J Immunol. 1990 May 15;144(10):3762–3769. [PubMed] [Google Scholar]
  34. Stohl W., Cunningham-Rundles C., Mayer L. In vitro induction of T cell-dependent B cell differentiation in patients with common varied immunodeficiency. Clin Immunol Immunopathol. 1988 Nov;49(2):273–282. doi: 10.1016/0090-1229(88)90117-1. [DOI] [PubMed] [Google Scholar]
  35. Tosato G., Gerrard T. L., Goldman N. G., Pike S. E. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6. J Immunol. 1988 Jun 15;140(12):4329–4336. [PubMed] [Google Scholar]
  36. Waldmann T. A., Durm M., Broder S., Blackman M., Blaese R. M., Strober W. Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet. 1974 Sep 14;2(7881):609–613. doi: 10.1016/s0140-6736(74)91940-0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES